Gliptozan plus

Indications for use

Monotherapy
Type II diabetes mellitus treatment as initial treatment to improve glycemic control when diet therapy and exercise adherence are ineffective;
Combined therapy;
Type II diabetes mellitus treatment in combination with hypoglycemic drugs.

Therapeutic class:

Combined oral hypoglycemic agent (dipeptidyl peptidase-4 inhibitor + biguanide)

INN

Metformin + Sitagliptin